Skip to content
10-Q

Quarterly Report

GENMED HOLDING CORP

0001178924-12-000183

← back to feed
Filed
Nov 16, 2012 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2012 · Sep 30, 2012 294.88M sh
Operating Cash Flow Q3 2012 · Sep 30, 2012 −$890.71K
Operating Cash Flow Q3 2012 · Sep 30, 2011 −$904.22K
Cash And Equivalents Q3 2012 · Sep 30, 2012 $36.22K
Cash And Equivalents Q3 2012 · Dec 31, 2011 $904.49K
Current Liabilities Q3 2012 · Sep 30, 2012 $320.75K
Current Liabilities Q3 2012 · Dec 31, 2011 $144.72K
Total Liabilities Q3 2012 · Sep 30, 2012 $2.89M
Total Liabilities Q3 2012 · Dec 31, 2011 $2.65M
Current Assets Q3 2012 · Sep 30, 2012 $106.53K
Current Assets Q3 2012 · Dec 31, 2011 $1.03M
Total Assets Q3 2012 · Sep 30, 2012 $109.6K
Total Assets Q3 2012 · Dec 31, 2011 $1.04M
Sga Expense Q3 2012 · Sep 30, 2012 $286.69K
Sga Expense Q3 2012 · Sep 30, 2012 $881.67K
Rd Expense Q3 2012 · Sep 30, 2012 $26.1K
Rd Expense Q3 2012 · Sep 30, 2012 $79.29K
Net Income Q3 2012 · Sep 30, 2012 −$310.02K
Net Income Q3 2012 · Sep 30, 2012 −$1.2M
Net Income Q3 2012 · Sep 30, 2011 −$394.46K
Operating Income Q3 2012 · Sep 30, 2012 −$311.3K
Operating Income Q3 2012 · Sep 30, 2012 −$961.14K
Revenue Q3 2012 · Sep 30, 2012 $2.29K
Revenue Q3 2012 · Sep 30, 2012 $2.29K